Sub menu

 
 

International scientific guideline: Note for guidance on the clinical investigation of medicinal products for the treatment of urinary incontinence

CPMP/EWP/18/01/Rev. 1 adopted by the Therapeutic Goods Administration (TGA)

About this guideline

Overseas effective date: 1 August 2014

Categories: Clinical efficacy and safety | Genito-urinary system and sex hormones

Replaces: CPMP/EWP/18/01 (Adopted by TGA 4 February 2004)

Access this international scientific guideline

For more information see International scientific guidelines adopted in Australia.

Where EU guidelines adopted in Australia include references to EU legislation (including EC Directives and Regulations), the requirements contained in the referenced EU legislation are not applicable to the evaluation of medicines by the TGA.

Help us improve the Therapeutic Goods Administration site